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Abstract
Background: Toll-like receptors (TLRs) have a central role in the recognition of pathogens and the initiation of the innate
immune response. Myeloid differentiation primary-response gene 88 (MyD88) and TIR-domain-containing adaptor protein
inducing IFNb (TRIF) are regarded as the key signaling adaptor proteins for TLRs. Melioidosis, which is endemic in SE-Asia, is
a severe infection caused by the gram-negative bacterium Burkholderia pseudomallei. We here aimed to characterize the
role of MyD88 and TRIF in host defense against melioidosis.
Methodology and Principal Findings: First, we found that MyD88, but not TRIF, deficient whole blood leukocytes released
less TNFa upon stimulation with B. pseudomallei compared to wild-type (WT) cells. Thereafter we inoculated MyD88 knock-
out (KO), TRIF mutant and WT mice intranasally with B. pseudomallei and found that MyD88 KO, but not TRIF mutant mice
demonstrated a strongly accelerated lethality, which was accompanied by significantly increased bacterial loads in lungs,
liver and blood, and grossly enhanced liver damage compared to WT mice. The decreased bacterial clearance capacity of
MyD88 KO mice was accompanied by a markedly reduced early pulmonary neutrophil recruitment and a diminished
activation of neutrophils after infection with B. pseudomallei. MyD88 KO leukocytes displayed an unaltered capacity to
phagocytose and kill B. pseudomallei in vitro.
Conclusions: MyD88 dependent signaling, but not TRIF dependent signaling, contributes to a protective host response
against B. pseudomallei at least in part by causing early neutrophil recruitment towards the primary site of infection.
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Introduction
Innate immune recognition is based on the detection of
molecular structures that are unique to microorganisms [1,2].
The Toll family of receptors (TLRs) has a central role as pattern
recognition receptors (PRRs) in the initiation of cellular innate
immune responses. TLRs can activate tissue-resident macrophages
to produce pro-inflammatory cytokines, including TNF-a and IL-
6, which coordinate local and systemic inflammatory responses
[1,3,4]. TLR signalling depends on the selective use by different
TLRs of five different adaptor molecules: myeloid differentiation
primary-response gene 88 (MyD88), TIR-domain-containing
adaptor protein inducing IFNb (TRIF), MyD88-adaptor-like
(MAL), TRIF-related adaptor molecule (TRAM) and sterile a-
and armadillo-motifcontaining protein (SARM) [5]. MyD88 and
TRIF are regarded as the main adaptor proteins. MyD88 is the
key signalling adaptor for all TLRs - with the exception of TLR3
and certain TLR4 signals –, the IL-1-receptor (IL-1R) and IL-18R
[5]; its main role is the activation of nuclear factor-kB (NF-kB).
MyD88 is directly recruited to the TIR (Toll/IL-1R) domains in
certain TLRs and acts to recruit IL-1R-associated kinase (IRAK)
4. TRIF is now known to control the TLR4-induced MyD88-
independent pathway, and also to be the exclusive adaptor used by
TLR3 [5–7]. MAL and TRAM both act as bridging adaptors,
with MAL recruiting MyD88 to TLR2 and TLR4, and TRAM
recruiting TRIF to TLR4 to allow for IFN regulatory factor (IRF)-
3 activation [3,5]. Finally, SARM has recently been shown to
function as a negative regulator of TRIF [5,8].
Given their central role in the recognition of microbes, TLR
signalling is likely to play a crucial role in the event of sepsis: on the
one hand TLR signalling is essential for the early detection of
pathogens, but on the other hand can cause excessive inflamma-
tion after uncontrolled stimulation [9–11]. Burkholderia pseudomallei,
a gram-negative bacterium that causes melioidosis and a
recognized biological threat agent, is one of the most important
causes of pneumonia-derived and community-acquired sepsis in
South-East Asia and northern-Australia [12,13]. We have recently
shown that both TLR2 and TLR4 contribute to cellular
responsiveness to B. pseudomallei in vitro, while only TLR2 impacts
on the immune response of the intact host in vivo [14]. In the
present study we sought to determine the contribution of MyD88
and TRIF in the innate immune response to B. pseudomallei and
found that MyD88, but not TRIF, signalling plays a crucial
protective role in experimental melioidosis at least in part by
causing early neutrophil recruitment to the site of infection.
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Mice
Pathogen-free 10 week old C57BL/6 wild-type (WT) mice were
purchased from Harlan Sprague Dawley Inc. (Horst, the Nether-
lands). MyD88 knockout (KO) mice backcrossed 6 times to a
C57BL/6 genetic background were generously provided by Dr.
Shizuo Akira (Osaka University, Japan) [15]. Mice deficient in
TRIF, generously provided by Dr. Bruce Beutler (Scripps
Research Institute, La Jolla, CA), were obtained by inducing
random germline mutations in C57BL/6 mice by using N-ethyl-
N-nitrosourea [16]. Age and sex-matched animals were used in all
experiments. The Animal Care and Use of Committee of the
University of Amsterdam approved all experiments.
In vitro stimulation
Whole blood, obtained from uninfected WT, MyD88 KO and
TRIF mutant mice by bleeding from the inferior vena cava, was
stimulated with heat-killed B. pseudomallei strain 1026b
(5610
7 CFU/ml) or RPMI for 16 hrs as described [14,17].
Supernatants were harvested and stored at 220uC until assayed
for TNFa release.
Experimental infection
For preparation of the inoculum, B. pseudomallei strain 1026b
[14,18,19] was used and streaked from frozen aliquots into 50 ml
Luria broth (Difco, Detroit, MI) for overnight incubation at 37uCi n
a5 %C O 2 incubator. Thereafter, a 1 ml portion was transferred to
fresh Luria broth and grown for 65 h to midlogarithmic phase.
Bacteriawere harvested bycentrifugationat15006g for 15 minutes,
washed and resuspended in sterile isotonic saline at a concentration
of 5610
2 CFUs/50 ml, as determined by plating serial 10-fold
dilutions on blood agar plates. We used the inoculation dose of
5610
2 CFU B. pseudomalleito be ableto compare our results with our
previous studies in TLR2 and TLR4 KO mice in which we used the
exact same dose [14]. Pneumonia was induced by intranasal
inoculation of 50 ml( 5 610
2 CFU) bacterial suspension. For this
proceduremicewerelightlyanesthetizedbyinhalationofisofluorane
(Upjohn, Ede, The Netherlands).
Determination of bacterial outgrowth
At designated time points after infection, mice were anesthetized
with HypnormH (Janssen Pharmaceutica, Beerse, Belgium: active
ingredients fentanyl citrate and fluanisone) and midazolam
(Roche, Mijdrecht, The Netherlands) and sacrificed by bleeding
from the inferior vena cava. The lungs and liver were harvested
and homogenized at 4uC in 4 volumes of sterile saline using a
tissue homogenizer (Biospec Products, Bartlesville, OK). CFUs
were determined from serial dilutions of organ homogenates and
blood, plated on blood agar plates and incubated at 37uCa t5 %
CO2 for 16 h before colonies were counted.
Assays
Lung homogenates were prepared as described earlier [14,20,21].
Mouse TNF-a, IFN-c, monocyte chemoattractant protein (MCP)-1,
IL-6 and IL-10 were measured by cytometric bead array (CBA)
multiplex assay (BDBiosciences, San Jose, CA) in accordance with
the manufacturer’s recommendations. Myeloperoxidase (MPO;
HyCult Biotechnology, Uden, the Netherlands), lipopolysaccha-
ride-induced CXC chemokine (LIX; R&D Systems, Minneapolis,
MN), KC and macrophage-inflammatory protein-(MIP)-2 (both
RnD systems,Minneapolis,MN) were measuredusingcommercially
available ELISA’s or antibody pairs. Aspartate aminotransferase
(ASAT) and alanine aminotransferase(ALAT)were determined with
commerciallyavailablekits(Sigma-Aldrich),usingaHitachianalyzer
(Roche) according to the manufacturer’s instructions.
Pathology
Lungs and liver for histology were prepared and analyzed as
described earlier [14,20,21]. To score lung inflammation and
damage, the entire lung surface was analyzed with respect to the
following parameters: surface with pneumonia, necrosis/abscess
formation, interstitial inflammation, endothelialitis, bronchitis, ede-
ma, thrombus formation and pleuritis. Each parameter was graded
o nas c a l eo f0t o4 ,w i t h0 :a b s e n t ,1 :m i l d ,2 :m o d e r a t e ,3 :s e v e r e ,4 :
very severe. The total ‘‘lung inflammation score’’ was expressed as
the sum of the scores for each parameter, the maximum being 32.
Liver sections were scored on inflammation, necrosis/abscess
formation and thrombus formation using the scale given above.
Flow cytometry
Lung cell suspensions were obtained by passing the lungs trough
a 40-mm cell strainer (BD, Franklin Lakes, NJ) as described
previously [22,23]. Erytrocytes were lysed with ice-cold isotonic
NH4Cl solution (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM
EDTA, pH 7.4); the remaining cells were washed twice with
RPMI 1640 (Bio Whiitaker, Verviers, Belgium), and counted by
suing a hemocytometer. The percentages of macrophages,
neutrophils and lymphocytes were determined using a FACSCa-
libur (BD, San Jose, CA). Cells were brought to a concentration of
1610
7 cells/ml in FACs buffer (PBS supplemented with 0.5%
PBS, 0.01% NaN3 and 0.35 mM EDTA). Immunostaining for cell
surface molecules was performed for 30 minutes at 4uC using
directly labeled antibodies (abs) against GR-1 (GR-1 FITC,
BDPharmingen, San Diego, California), CD11b (CD11b-phyco-
erythrin, BDPharmingen) and a biotin labeled antibody against
F4/80 (Serotec, Oxford, United Kingdom) in combination with
streptavidin allophycocyanine. All abs were used in concentrations
recommended by the manufacturer (BD Pharmingen, San Diego,
CA). After staining, cells were fixed in 2% paraformaldehyde.
Neutrophils were counted using the scatter pattern and GR-1 high
gate, monocytes in the sidescatter low and F4/80 postive gate and
macrophages in the sidescatter high and F4/80 positive gate.
Phagocytosis and bacterial killing assays
Phagocytosis was evaluated inessenceasdescribed before [24,25].
Concentrated B. pseudomallei preparation was treated for 90 minutes
at 38uC with 100 mg/ml mitomycine-C (Sigma-Aldrich, Zwijn-
drecht, the Netherlands) to prepare alive but growth-arrested
bacteria. To determine the neutrophil phagocytosis capacity, 50 ml
of whole blood was incubated with carboxyfluorescein-diacetate-
succinimidyl-ester (CFSE dye, Invitrogen, Breda, the Netherlands)
labeled, growth-arrested bacteria (1610
7 CFU/ml) and incubated
for 10, 60 or 120 minutes at 37uC. Cells were suspended in
Quenching solution, incubated in FACS lysis/fix solution (BD,
Mountain View, CA) and neutrophils were labeled using anti-Gr-1-
PE (BD Pharmingen, San Diego, CA). Cells were washed with ice-
cold FACS buffer after which the degree of phagocytosis of
neutrophils was determined using FACSCalibur (Becton Dickinson;.
1610
4 neutrophils were analysed per sample). The phagocytosis
index of each samples was calculated as follows: (mean fluores-
cence6% positive cells at 37uC) minus (mean fluorescence6%
positive cells at 4uC). Bacterial killing was determined as described
[26]. In brief, peritoneal macrophages were harvested from WT and
MyD88 KOmiceand platedasdescribed above(n=5 per strain).B.
pseudomallei was added at a multiplicity of infection (MOI) of 50 and
spun onto cells at 2000 rpm for 5 minutes, after which plates were
placed at 37uC for 10 minutes. Each well was then washed 5 times
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bacterial uptake after 10 minutes, wells were lysed with sterile dH2O
and designated as t=0. RPMI was added to remaining wells and
plates were placed at 37uC for 10 or 60 minutes after which cells
were again washed 5 times with ice-cold PBS and lysed with dH2O.
Cell-lysates were plated on blood agar plates and bacterial counts
were enumerated after 16 h. Bacterial killing was expressed as the
percentage of killed bacteria in relation to t=0.
Statistical analysis
All data are expressed as mean6SEM. Difference between
groups were analyzed with Mann-Whitney U test or Kruskal-
Wallis analysis with Dunn post hoc test where appropriate. For
survival analyses, Kaplan-Meier anlyses followed by log-rank test
was performed. These analyses were performed using GraphPad
Prism version 4 (GraphPad Software, San Diego, CA). Values of
p,0.05 were considered statistically significant.
Results
MyD88 but not TRIF is required for cellular
responsiveness to B. pseudomallei in vitro
To obtain a first insight into the function of the TLR adaptor
molecules MyD88 and TRIF in melioidosis, we tested the
requirement of MyD88 and TRIF signaling upon first encounter
between B. pseudomallei and the host. Therefore, we tested the
capacity of whole blood harvested from WT, MyD88 KO and
TRIF mutant mice to release TNFa upon stimulation with B.
pseudomallei. MyD88 deficient leukocytes, but not TRIF deficient
leukocytes, released less TNFa than WT leukocytes upon
stimulation with heat-killed B. pseudomallei in vitro (Fig. 1),
suggesting that MyD88, and not TRIF, contributes to cellular
responsiveness towards B. pseudomallei in vitro.
MyD88 KO, but not TRIF mutant, mice show an
accelerated mortality during experimental melioidosis
We next investigated the involvement of MyD88 and TRIF in
the host response to B. pseudomallei infection in vivo. As a first
experiment WT, MyD88 KO and TRIF mutant mice were
intranasally infected with a lethal dose of B. pseudomallei and
followed for one week. MyD88 deficiency had a markedly negative
influence on survival: whereas all WT mice were dead after
160 hours (median survival time 118 hours), all MyD88 KO mice
died within 88 hours (median survival time 76 hours; P,0.001 for
the difference between groups; Fig. 2A). TRIF deficiency on the
other hand did not impact on survival during experimental
melioidosis (Fig. 2B).
MyD88 but not TRIF contributes to bacterial clearance of
B. pseudomallei in vivo
To obtain insight into the mechanisms underlying the
accelerated mortality of MyD88 KO mice during experimental
melioidosis, we infected WT and MyD88 KO mice with B.
pseudomallei and sacrificed them after 24 (i.e. just before the first
symptoms of illness occurred) and 72 hours (i.e. before the first
deaths occurred) to determine bacterial loads in lungs (the primary
site of the infection), liver and blood (to evaluate dissemination to
distant body sites; Fig. 3). Relative to WT mice, MyD88 KO mice
displayed strongly increased pulmonary and systemic bacterial
loads at 24 and 72 hours after infection, as well as in their livers at
72 hours (Fig. 3). Conversely, similar bacterial loads in the lungs,
liver and blood of WT and TRIF mutant mice were observed
72 hours after infection with B. pseudomallei (Fig. 4).
Role of MyD88 and TRIF in B. pseudomallei induced
pulmonary inflammation
The success of combating infection strongly depends on the
generation of an effective inflammatory response at the primary
site of infection [11,27]. Therefore, to further investigate the role
of MyD88 and TRIF in the inflammatory response towards
Figure 1. MyD88, but not TRIF, is required for cellular
responsiveness to B. pseudomallei in vitro. Whole blood of wild-
type (WT; white bars), MyD88 knock-out (KO; grey bars) and TRIF
mutant (black bars) mice were incubated with RPMI 1640 medium or
heat-killed (HK) B. pseudomallei (5610
7 CFU)/ml) for 16 hours before
TNFa production was measured in the supernatant. Data are mean-
s6SEM (n=5–6/strain); * P,0.05.
doi:10.1371/journal.pone.0003494.g001
Figure 2. MyD88 KO, but not TRIF KO, mice show an accelerated mortality during experimental melioidosis. Survival of wild-type (WT,
open rounds) and MyD88 KO mice (black squares) (A) or TRIF mutant (black squares) mice (B) intranasally infected with 5610
2 CFU B. pseudomallei.
Mortality was assessed twice daily for one week. n=8–10 per group; ns denotes not significant; P value indicates the difference between MyD88 KO
and WT mice.
doi:10.1371/journal.pone.0003494.g002
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whole lung homogenates harvested from WT, MyD88 KO and
TRIF mutant mice after intranasal infection with B. pseudomallei
(Table 1). 24 h after infection, pulmonary TNFa, MCP-1 and
IL-10 were lower in MyD88 KO mice relative to WT mice
(Table 1). At 72 h after infection TNFa levels remained lower in
MyD88 KO mice, while MCP-1 and IL-6 levels tended to be
higher in these animals (Table 1). In addition, histological
samples of lungs obtained 24 and 72 hours after infection were
semi-quantitatively scored on the extent of inflammation.
Pulmonary inflammation was characterized by significant inflam-
mation, pleuritis, peribronchial inflammation, oedema and
endothelialitis in both WT and MyD88 KO mice (Fig. 5).
MyD88 KO mice tended to have more lung injury compared to
WT mice, however lung inflammation scores were not significantly
different at 72 hours after infection between both mice strains
(data not shown). Pulmonary cytokine levels and lung inflamma-
tion scores were similar in TRIF mutant and WT mice at all time
points (data not shown).
Enhanced liver damage in MyD88 KO mice
After the lung, the liver is one of the most commonly affected
organs in melioidosis [12,28]. Considering this and the observed
increased bacterial loads in the liver, we examined the influence of
MyD88 deficiency on liver damage 72 h post infection. Upon
histopathological examination, both WT and MyD88 KO mice
showed mild inflammation of liver tissue as characterized by the
influx of leukocytes into the hepatic parenchyma (Fig. 6A–B).I n
contrast to WT mice, MyD88 KO mice showed foci of liver
necrosis and the formation of small abscesses (Fig. 6B). In line,
the extent of hepatic inflammation as quantified according to the
scoring system described in Materials and Methods section was
significantly increased in MyD88 KO mice compared to controls
(Fig. 6C). The increased hepatocellular injury in MyD88 KO
mice after infection with B. pseudomallei was further underscored by
clinical chemistry: MyD88 KO mice displayed strikingly higher
plasma levels of ASAT and ALAT compared to WT mice
(Fig. 6D–E).
No role of MyD88 in phagocytosis of B. pseudomallei
The experiments described above established the key role of
MyD88 in the antibacterial defense towards B. pseudomallei
infection. MyD88 has been described to play an important role
Figure 3. MyD88 KO mice show increased bacterial outgrowth during experimental melioidosis. WT and MyD88 KO mice were
intranasally infected with B. pseudomallei (5610
2 CFU). Bacterial loads were measured 24 h and 72 h after inoculation in lungs (A), liver (B) and blood
(C). Data are mean6SEM (n=6–7 per group at each time point). ** P,0.01.
doi:10.1371/journal.pone.0003494.g003
Figure 4. TRIF deficiency does not impact on bacterial outgrowth during experimental melioidosis. WT and TRIF mutant mice were
intranasally infected with B. pseudomallei (5610
2 CFU). Bacterial loads were measured 72 h after inoculation in lungs (A), liver (B) and blood (C). Data
are mean6SEM (n=8 per group at each time point); ns denotes not significant.
doi:10.1371/journal.pone.0003494.g004
Table 1. Role of MyD88 in B. pseudomallei induced
pulmonary cytokine levels.
pg/ml WT MyD88 KO WT MyD88 KO
t=24 t=72
TNF-a 50618 1062* 10486266 314633**
IFN-c BD BD 1163B D
MCP-1 9936255 245646* 635461379 9950632
IL-6 4876122 85615 14186869 29906456
IL-10 120648 28611* 278653 68616
Groups of 5–7 mice were intranasally inoculated with 5610
2 CFU B.
pseudomallei. After 24 and 72 h mice were sacrificed, lungs were removed,
homogenized and cytokines were measured. Data are expressed as
mean6SEM; BD: below detection; * P,0.05; ** P,0.01 versus WT controls.
doi:10.1371/journal.pone.0003494.t001
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pseudomallei is a facultative intracellular bacterium [13,29–31] we
next determined whether MyD88 contributes to phagocytosis
and/or killing of B. pseudomallei. Interstingly, we found that MyD88
deficient neutrophils demonstrated an unaltered capacity to
phagocytose B. pseudomallei (Fig. 7A). In addition, no difference
in the killing capacity between WT and MyD88 deficient
macrophages was observed (Fig. 7B).
MyD88 plays an important role in the early neutrophil
recruitment after infection with B. pseudomallei
To further dissect the mechanism for the strong protective role
of MyD88 during experimental melioidosis and in light of recent
data suggesting that MyD88 is necessary for early neutrophil
recruitment during hypersensitivity pneumonitis [32] as well as
pulmonary infection with Pseudomonas aeruginosa [33], we investi-
gated the role of MyD88 in neutrophil recruitment in our model.
Figure 5. Pulmonary inflammation in mice infected with B. pseudomallei. Representative histopathology slides of lungs of WT (A) and
MyD88 KO (B) mice infected with 5610
2 CFU B. pseudomallei at 72 h after infection showing significant infilates, edema and peribronchial
inflammation. The preparations were stained with haematoxylin and eosin. Original magnification, 650.
doi:10.1371/journal.pone.0003494.g005
Figure 6. Enhanced liver damage in MyD88 KO mice. Representative hematoxylin- and eosin-stained liver histology slides for WT (A) and
MyD88 KO (B) mice at 72 h after inoculation with 5610
2 CFU B. pseudomallei show more inflammation and foci of necrosis (as indicated by the
asterisk) in the livers derived from MyD88 KO animals compared to WT controls (original magnification,6400) corresponding with higher pathology
scores (see Methods section) (C). At 72 h after inoculation MyD88 KO mice also showed enhanced hepatic injury, as reflected by the plasma
concentrations of aspartate aminotransferase (ASAT) (D) and alanine aminotransferase (ALAT) (E). Data are mean6SEM (n=5–6 per group); U/L, units
per liter; * P,0.05; ** P,0.01.
doi:10.1371/journal.pone.0003494.g006
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MyD88 KO mice after inoculation with B. pseudomallei.A t
24 hours after infection, MyD88 KO mice had significantly fewer
neutrophils in their lungs compared with WT mice (Table 2 and
Fig. 8A). In addition to a lower absolute amount of neutrophils in
MyD88 KO mice, the neutrophils that were recruited were also
less activated as demonstrated by both diminished CD11b
positivity (Fig. 8B) and decreased pulmonary MPO content
(Fig. 8C). In line, local levels of the neutrophil attracting
chemokines MIP-2 and KC tended to be lower or were
significantly reduced in MyD88 KO mice at 24 hours after
infection (Fig. 8D–E). The pulmonary levels of LIX, a murine
neutrophil-chemoattractant CXC chemokine [34], did not differ
between WT and MyD88 KO mice at this early time point
(Fig. 8F). Together these data suggest that the protective effect of
MyD88 in the host defense against melioidosis can at least in part
be explained by MyD88 dependent neutrophil recruitment
following exposure to B. pseudomallei.
Discussion
The identification of the TLR family in conjunction with their
specific signaling pathways has led to an explosion of knowledge in
understanding both the physiological and pathophysiological role
of these innate immune signaling pathways in the event of sepsis
[3,4,9–11]. Although our knowledge on the role of the innate
immunity in the pathogenesis of sepsis caused by B. pseudomallei has
progressed rapidly over the past years [13], much is unclear about
which TLR signaling pathways are activated and how these TLR
initiated signals are integrated into the more general infrastructure
of the host defense in which they operate. The melioidosis mouse
model in which B. pseudomallei is delivered per the intranasal route
has been proven successful in mimicking pneumonia-derived
septic melioidosis [13,14,17,19–21,35,36] and the availability of
MyD88 and TRIF deficient mice enabled us to further elucidate
the predominant TLR signaling routes involved in melioidosis. We
found that MyD88, but not TRIF, plays an important protective
role in the host defense against B. pseudomallei in vivo. MyD88
deficient, but not TRIF mutant whole blood leukocytes released
less TNFa upon stimulation with B. pseudomallei compared to WT
cells. In addition, during experimental melioidosis MyD88 KO
mice, but not TRIF mutant mice, demonstrated strongly increased
lethality, accompanied by significantly increased bacterial loads
when compared to WT mice. The decreased bacterial clearance
capacity of MyD88 KO mice was accompanied by markedly
reduced early pulmonary neutrophil recruitment and a diminished
activation of neutrophils. These results further contribute to our
understanding of the pathogenesis of sepsis in general and severe
melioidosis in particular by revealing the important protective role
of the MyD88 dependent signaling pathway by causing early
neutrophil recruitment following B. pseudomallei exposure.
Our data are in line with other studies showing the crucial role
of MyD88 in host defense against infection with both gram-
positive [32,37–39] and gram-negative bacteria [33,40–44]. More
specifically, our current results now further add to accumulating
evidence that MyD88 is necessary for neutrophil recruitment
during pneumonia [32,33,40,42]. Neutrophils are known to play a
critical role in the host defense against B. pseudomallei [36]. During
murine melioidosis activated neutrophils are rapidly recruited to
the lungs after intranasal infection with B. pseudomallei [17,36]. In
addition, depletion of neutrophils with anti-GR-1+ antibody
severely exacerbated disease and was associated with a 1000-fold
increase in pulmonary bacterial loads within 4 days [36]. We now
show that during experimental melioidosis MyD88 is crucially
involved in protective neutrophil recruitment. We further extend
these findings by showing the importance of MyD88 in the
activation of neutrophils as demonstrated by reduced CD11b
expression on MyD88 KO neutrophils. The early diminished
neutrophil recruitment was accompanied by reduced levels of the
CXC chemokines KC and MIP-2, but unaltered early LIX levels,
suggesting that MyD88 deficiency at least in part diminishes
neutrophil influx during pneumonia derived melioidosis due to an
attenuated production of CXC chemokines at the primary site of
the infection. Notably, the observed decrease in neutrophil
recruitment in the infected MyD88 KO mice was associated with
decreased levels of TNFa, MCP-1 and IL-10 signifying that
MyD88 is required for the induction of these cytokines. Of
interest, the levels of some cytokines, most notably IL-6 and MCP-
1, tended to be higher in MyD88 KO compared to WT mice at
72 hours after inoculation (non significant). Clearly, MyD88-
independent pathways are also involved in proinflammatory
cytokine production, which is in line with observations in
MyD88 KO mice after pulmonary infection with Haemophilus
influenzae [43].
Figure 7. No difference in B. pseudomallei phagocytosis or killing capacity between WT and MyD88 KO cells. (A) Peripheral blood
neutrophils were incubated at 37uC with CFSE-labeled growth-arrested B. pseudomallei (1610
7 CFU/ml) after which time-dependent phagocytosis
was quantified; 1610
4 neutrophils were analysed per sample (see Methods section). (B) Killing capacity of peritoneal macrophages are shown as
percentage of killed B. pseudomallei compared to t=0. Data are mean6SEM; n=5 per mouse strain. Open rounds represent WT cells, while black
squares represent MyD88 KO mice; ns denotes not significant.
doi:10.1371/journal.pone.0003494.g007
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phagocytosis or killing of the facultative intracellular B. pseudomallei.
This is in contrast with one earlier report describing MyD88 to be
important in phagocytosis and killing of invading bacteria [26],
but does correspond with more recent evidence arguing against a
role of TLR-signalling in phagocytosis [45,46]. One of the ways in
which phagocytic cells are able to kill engulfed microbes is through
the production of bactericidal reactive oxygen species via the
NADPH oxidase enzyme complex [47,48]. Breitbach et al.
convincingly demonstrated that NADPH oxidase is essential in
controlling intracellular B. pseudomallei [49]. Mice that are deficient
for gp91phox, one of the two membrane bound components of the
NADPH oxidase complex, have a accelerated mortality after
infection with B. pseudomallei [49]. Given the fact that NADPH
oxidase function is partially controlled by MyD88 [47], it is
surprising that we were unable to detect a difference in
intracellular numbers of B. pseudomallei between WT and MyD88
deficient macrophages after one hour of incubation. We cannot
exclude that MyD88 dependent modulation of NADPH oxidase
activity does play a role at later time point after cellular infection.
Further research is needed to dissect the interaction between
MyD88 and NADPH oxidase during melioidosis.
Remarkably, MyD88 KO and WT mice displayed similar lung
pathology at 72 hours after infection. Thus, neutrophil recruit-
ment was relatively selectively influenced by MyD88 deficiency in
the context of the lung inflammatory response as a whole. It
should be noted that MyD88 KO mice had much higher bacterial
loads in their lungs than WT mice, and one could therefore argue
that MyD88 KO mice had a relatively attenuated inflammatory
pulmonary response. Nonetheless, our data indicate that even in
Figure 8. MyD88 plays an important role in early neutrophil recruitment after infection with B. pseudomallei. The impact of MyD88
deficiency on early neutrophil recruitment was investigated by analysing the amount of neutrophils in the pulmonary compartment using FACS
analysis (see Methods) 24 h after intranasal inoculation of WT and MyD88 KO mice with 5610
2 CFU B. pseudomallei. MyD88 KO mice displayed
significantly fewer neutrophils in their lungs compared with WT mice (the percentages of neutrophils of the total pulmonary cell count are given
from one respresentative WT and one respresentative MyD KO mouse) (A). Additionally, MyD88 deficient neutrophils (gray line and gray bars)
present at t=24 expressed less CD11b on their surface compared to WT neutrophils (black line and white bars): representative histograms show
decreased CD11b expression on pulmonary neutrophils (B). This corresponded with lower MPO levels in lung homogenates of MyD88 KO mice (gray
bars) compared to controls (white bars) (C). In line, pulmonary MIP-2 (D) and KC (E) levels tended to be lower or were significantly reduced in MyD88
KO mice. LIX levels were unaltered in MyD88 KO mice at this early time point (F). SSC, side scatter; FITC: fluorescein isothiocyanate; PE, phycoerythrin;
MFI, mean fluorescence intensity; MPO, Myeloperoxidase; MIP-2: macrophage-inflammatory protein-2; LIX, lipopolysaccharide-induced CXC
chemokine. Bar figures represent mean6SEM; n=6–8 per mouse strain. * P,0.05; ** P,0.01.
doi:10.1371/journal.pone.0003494.g008
Table 2. Effect of MyD88 deficiency on total and differential lung cell counts.
Leukocytes Macrophages Monocytes Neutrophils Lymphocytes/Other
610
5/ml % % % %
WT 23612 0 611 3 612 5 634 2 62
MyD88 KO 10612 1 611 2 616 61** 6061**
Total leukocyte counts (610
5/ml) and differential cell counts in lungs of wild-type (WT) and MyD88 knock-out mice 24 hours after intranasal infection with 5610
2 CFU of
B. pseudomallei. Data are mean6SEM (n=6–7/group); ** P,0.01 versus WT.
doi:10.1371/journal.pone.0003494.t002
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all relevant TLRs as well as of the IL-1R and IL-18R, B.
pseudomallei is still able to elicit profound inflammation in the
pulmonary compartment. Further research is warranted which
MyD88 independent components of the innate immune system
contribute herein.
Bacterial dissemination to the liver and the formation of liver
abscesses is one of the hallmarks of melioidosis septic shock [12,13].
We now show that MyD88 KO mice display a markedly increased
susceptibility to liver injury as indicated by increased histopathology
scores and clinical chemistry levels. The MyD88 pathway has
recently been shown to be essential for early liver restoration after
partial hepatectomy [50]. Furthermore, in a model of sepsis caused
by polymicrobial infection both systemic and hepatic inflammatory
responses were strongly attenuated in the absence of MyD88 [51].
Our current data indicate that in melioidosis MyD88 deficiency
results in increased hepatocellular injury most likely due to the much
higher bacterial loads inthe liver. In addition, these data suggestthat
MyD88 dependent signaling is not required for the occurrence of
liver inflammation and injury.
In addition of being the key signalling adaptor of virtual all TLRs,
MyD88 also serves as the main adaptor molecule for the IL-1R and
the IL-18R [5]. It has been shown in vitro that B. pseudomallei is
capable of inducing caspase-1 dependent death in macrophages
which is accompanied by the release of IL-1b and IL-18 [52].
Indeed, both IL-1b and IL-18 are known to be upregulated during
melioidosis [20,53,54]. Our current data can now be brought in line
with more recent findings showing the importance of IL-18 in the
host defense against melioidosis: mice treated with anti-IL18R
antibody [55] or IL-18 KO mice [20] have similar phenotypes as
MyD88 KO mice as they all show a markedly increased
susceptibility to infection with B. pseudomallei. It remains to be
established to what extent TLR dependent MyD88 signaling
contributes to the phenotype of MyD88 KO mice in experimental
melioidosis. We have previously reported on the role of TLR2 and
TLR4 in the host defense against B. pseudomallei and found that
although both TLR2 and TLR4 contribute to cellular responsive-
ness to B. pseudomallei in vitro only TLR2 impacts on the immune
response of the intact host in vivo [14]. Specifically, TLR2 KO mice
were strongly protected against B. pseudomallei induced mortality,
which was accompanied by much lower bacterial loads in lungs and
livers [14]. Since TLR2 signaling fully relies on MyD88 [3,5], these
results imply that complete MyD88 deficiency overrules the
protective effect of TLR2 restricted MyD88 signaling. Our own
preliminary results do not point toward an important role for TLR9
in host defense against B. pseudomallei (Wiersinga W.J. et al,
unpublished). A likely MyD88 dependent candidate within the
TLR family as a mediatorof protective immunity againstmelioidosis
is TLR5, which recognizes flagellin, an important component of B.
pseudomallei[13,56].The first studies using TLR5 KOmiceareabout
to be initiated in our laboratory. Together, these data indicate that
MyD88 deficiency results in a strongly impaired resistance against
melioidosis likely due to a combined deficiency in IL-1R, IL-18R
and possibly TLR5 signaling, and in spite of an interruption of
harmful TLR2 signaling.
Two earlier studies documented a reduced innate immune
response and a diminished bacterial clearance in TRIF deficient
mice with experimentally induced gram-negative pneumonia
caused by either Escherichia coli or Pseudomonas aeruginosa [57,58].
Our laboratory, however, reported that MyD88 but not TRIF is
important in clearing non-typeable Haemophilus influenzae from the
mouse lung [43]. We now show that TRIF does not play a role in
the host defense against B. pseudomallei, which is in full
correspondence with the earlier found limited role of TLR4 in
this gram-negative infection [14].
We conclude that MyD88 dependent signaling contributes to a
protective host response against B. pseudomallei at least in part by
causing early neutrophil activation and recruitment towards the
site of infection. In addition our study reveals that the role of TRIF
signaling is of minor importance for the clearance of infection with
B. pseudomallei.
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